By
AmyT on
March 13, 2013
Neal Kaufman is not only the husband of famed endocrinologist and Medtronic exec Fran Kaufman; he’s also a diabetes guru of sorts in his own right. He’s an experienced clinician and educator who founded a company called DPS Health (Diabetes Prevention Source), that offers an intense coaching program using technology + real-life interventions to help people with pre-diabetes and type 2 diabetes improve their lifestyles. Like us, he’s extremely interested in all sorts of D-technologies…
Read more »
By
MikeH on
January 11, 2013
By January 2015, we could be offered a choice of wearing a dual-chambered infusion pump that distributes both insulin and another medication like fast-acting glucagon or a meal-time infusion of Symlin.
Could be… that’s the tentative timeline for a new device being developed as part of a partnership between the JDRF and Tandem Diabetes, maker of the Apple-esque t:slim insulin pump that debuted in 2012. On Tuesday, the two entities announced they’ve teamed up to…
Read more »
By
WilD on
December 19, 2012
A few months ago, we got a tip from a researcher about a new product from a company called Tethys Bioscience that can quite accurately predict a person’s likelihood of developing type 2 diabetes. This sounded pretty revolutionary, in large part because it has the potential to save the country billions of dollars in diabetes prevention. But does knowing your risk actually motivate people?! They’ve teamed up with a popular smartphone health app to find…
Read more »
In most areas of diabetes research, you don’t hear much until there’s a big breakthrough of some sort. And then it goes dark again.
That’s what happened several years ago on the then-hot topic of xenotransplantation, or the sourcing of islet cells for transplants. Some studies were launched using porcine cells and the press had a field day with headlines like “pig sushi diabetes trial.” Since then? Nada.
But recently, a New Zealand-based company called…
Read more »
By
AmyT on
November 13, 2012
At last week’s Diabetes Technology Society Meeting in Bethesda, MD, Dexcom’s VP of Science & Technology Tom Peyser presented a brand new metric for glycemic variability based on CGM data that may be much more useful and easier to understand than Standard Deviation.
“Glycemic variability” is of course a fancy name for how out-of-control your blood sugar levels are. Swinging between severe ups and downs all the time (high variability) puts you at risk for…
Read more »
